https://www.dovepress.com/invasive-breast-cancer-with-her2-40-and-60-risk-classification-and-mol-peer-reviewed-fulltext-article-BCTT
0
0
8/3/23 at 5:41am
Organization
Dovepress.com
Author
Dove Press
To investigate the HER2 status and clinicopathological features in invasive breast cancer with HER2 ≥4.0 and
Create an account
or login to join the discussion